Position in VTGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,300
-$31,578 QoQ
Shares Held
57,830
-26.6% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 48 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in VTGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. VTGN ranks #439 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in VTGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,300 | 57,830 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $44,878 | 78,736 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $34,315 | 51,993 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $91,117 | 25,667 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $45,626 | 22,813 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $64,447 | 25,779 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $390,326 | 132,314 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $30,464 | 10,121 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $67,045 | 19,266 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $25,005 | 4,736 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $601 | 117 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $7,849 | 1,498 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $218 | 117 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $23,671 | 197,268 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $18,264 | 182,646 | Shares | Sole | 2023-02-08 | |
| 2022-06-30 | $20,644 | 23,461 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $16,023 | 12,922 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $871,235 | 446,788 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $584,213 | 213,217 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $787 | 250 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $23,001 | 10,799 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $38,993 | 20,100 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $14,192 | 20,276 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $41,085 | 77,521 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $12,599 | 28,637 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||